- Home
- ATUS vs RCUS Comparison
ATUS vs RCUS Comparison
Compare ATUS & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- RCUS
- Stock Information
- Founded
- ATUS 2015
- RCUS 2015
- Country
- ATUS United States
- RCUS United States
- Employees
- ATUS N/A
- RCUS N/A
- Industry
- ATUS Cable & Other Pay Television Services
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- RCUS Health Care
- Exchange
- ATUS Nasdaq
- RCUS Nasdaq
- Market Cap
- ATUS 1.0B
- RCUS 906.4M
- IPO Year
- ATUS 2017
- RCUS 2018
- Fundamental
- Price
- ATUS $2.56
- RCUS $9.38
- Analyst Decision
- ATUS Buy
- RCUS Buy
- Analyst Count
- ATUS 6
- RCUS 9
- Target Price
- ATUS $2.88
- RCUS $20.86
- AVG Volume (30 Days)
- ATUS 6.2M
- RCUS 1.1M
- Earning Date
- ATUS 08-07-2025
- RCUS 08-07-2025
- Dividend Yield
- ATUS N/A
- RCUS N/A
- EPS Growth
- ATUS N/A
- RCUS N/A
- EPS
- ATUS N/A
- RCUS N/A
- Revenue
- ATUS $8,855,764,000.00
- RCUS $141,000,000.00
- Revenue This Year
- ATUS N/A
- RCUS N/A
- Revenue Next Year
- ATUS N/A
- RCUS $28.73
- P/E Ratio
- ATUS N/A
- RCUS N/A
- Revenue Growth
- ATUS N/A
- RCUS N/A
- 52 Week Low
- ATUS $1.52
- RCUS $6.50
- 52 Week High
- ATUS $3.20
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- ATUS 64.06
- RCUS 57.71
- Support Level
- ATUS $2.53
- RCUS $8.03
- Resistance Level
- ATUS $2.79
- RCUS $9.97
- Average True Range (ATR)
- ATUS 0.13
- RCUS 0.47
- MACD
- ATUS 0.07
- RCUS 0.11
- Stochastic Oscillator
- ATUS 74.61
- RCUS 71.32
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.